Global Rabies Diagnostics Market by Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), by Technology (PCR, ELISA) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Industry Insights

Global rabies diagnostics market was valued at USD 1.47 Billion in 2017. It is expected to grow at a CAGR 4.1% over the forecast period. Neglected Tropical Diseases (NTDs), have been affecting many densely populated areas in low-resource settings around the world. Rabies is one such NTD that continues to be a threat to animal and human health, especially in Asian and African countries.

Many international healthcare organizations have been working together to develop and commercialize novel detection assays in order to support the fight against the disease. The World Health Organization (WHO) is one example of an international organization that promotes research efforts for rabies control around the world. The WHO also published several documents that illustrate various aspects of a comprehensive program to control this disease. These ongoing activities in the rabies market will fuel demand for reliable diagnostic solutions.

Most commercial tests currently use an antemortem diagnosis for human rabies virus. There are many options for tests that can be used, depending on their cost and efficiency. Internationally recommended tests are preferred by national laboratories that use validated equipment and reagents for virus detection.

However, small and remote provincial laboratories can use simpler chemical stain tests at a lower cost. This test has a low accuracy, however. The sample with negative results from a provincial laboratory will be taken to a national laboratory for further testing.

This creates additional costs and delays in effective infection control. These problems have prompted the development of innovative solutions to address the unmet needs of physicians and other entities involved in controlling infections.

LN34 panlysavirus real time RT-PCR assay was tested for efficiency in post-mortem diagnosis of rabies. The LN34 test is simpler and more straightforward to use. In Indonesia, the Rabies Immunoperoxidase antigen detection (RIAD) test was also developed in 2017. It is a cost-effective solution that provides accurate results. Awareness and adoption of new tests that improve disease testing in resource-poor as well as developed countries is expected to increase.

Diagnostic Method Insights

The presence of both conventional and novel molecular testing is driving the rabies market. Fluorescent antibody test (FAT), histological examination and immunohistochemical techniques such as Rapid Rabies Enzyme Immunodiagnosis, (RREID), are all examples of conventional methods.

The latest diagnostic tests include immunohistochemical tests like Direct Rapid Immunohistochemical Test, RIDT, Indirect Rapid Immunohistochemistry Test and nucleic acids detection techniques. FAT is the most commonly used test and is recommended by WHO and the World Organization for Animal Health.

These factors were responsible for the largest percentage of FAT in 2017, This test has advantages over other methods because it offers enhanced specificity, and sensitivity. In the near future, however, amplification and nucleic acid detection methods will be a major source of revenue growth.

Although molecular tests are not recommended for routine postmortem diagnosis, amplification methods/nucleic acids detection techniques are promising. These tests are used as an addition to traditional tests for antemortem or postmortem testing. These methods allow for quick and easy testing of samples. They also have a higher sensitivity than conventional assays.

Technology Insights

ELISA/Immunohistochemistry accounted for the largest market share owing to the higher penetration of products based on ELISA/immunohistochemistry protocols. This technology is used in many test methods, including FAT, RREID (dRIT), RIDT, IRIT, and dRIT. Immunohistochemistry These methods have significant advantages which have led to a high adoption of the technology. This will in turn drive the segment growth over the next years.

Some advantages associated with immunohistochemistry-based methods include cost-effectiveness, relative ease of interpretation using an ordinary light microscope, and less time consumption. IHC-based methods can also be applied to frozen and preserved samples, increasing their adoption rate.

PCR-based methods will see the greatest growth over the forecast period due to their ability to perform both antemortem rabies testing and postmortem rabies tests. Real-time PCR based tests are also considered a universally valid assay to test for Lyssaviruses.

Regional Insights

Although rabies is found in more than 100 and fifty countries and territories worldwide, the majority of cases are in Asia and Africa. According to the WHO, rabies causes 31,000 deaths annually in Asia each year. The WHO also stated that China has reported more than 2,000 deaths per year over the past decade, which is lower than India. These statistics and data have highlighted the need to create control programs that will drive market growth in the coming years.

Due to the high use of diagnostic tests in the United States, the market for American products is expected to expand significantly over the forecast period. According to the Centers for Disease Control and Prevention, more than 120,000 animals in the United States are tested for rabies each year.

Numerous diagnostic agencies are present in the country which contributes to the higher revenue share. However, Europe is home to most countries that are rabies-free. According to veterinary records, the U.K. was subject to reemergence of the disease starting in 2000. The country was declared rabies-free back in 1902.

Market Share Insights from Rabies Diagnostics

Bio-Rad Laboratories Inc., Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics; Norgen Biotek Corp., Abbexa Ltd., Express Biotech International Inc., BioNote, Inc., and MyBioSource.com are some of the key players in this market.

These companies collaborate with healthcare organizations to eradicate the disease by developing vaccine programs. They offer diagnostic tools that are required for mapping the prevalence, monitoring the impact of Mass Drug Administration (MDA), reducing MDA and post-elimination surveillance.

While some companies develop products for diagnostic purposes, others focus on developing products for research. Abbexa Ltd, for example, develops and markets products solely for research purposes.

Report Scope

The Report Covers Certain Segments

This report predicts revenue growth at the global, regional and country level and offers an analysis of industry trends in each sub-segment from 2014 to 2025. Grand View Research has divided the global rabies diagnostics industry report by diagnostic method, technology, region.

• Diagnostic Method Outlook (Revenue USD Million, 2014-2025)

  • Fluorescent Antibody Testing (FAT).

  • Immunohistochemical test

  • Methods of amplifying

  • Histologic Examination

  • Serology Tests

• Technology Method Outlook (Revenue USD Million, 2014-2025)

  • ELISA/Immunohistochemistry

  • Chromatography Techniques

  • PCR

  • Other

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • The U.S.

    • Canada

  • Europe

    • U.K.

    • Spain

  • Asia Pacific

    • India

    • China

    • Indonesia

  • Latin America

    • Brazil

  • Middle East & Africa

    • South Africa

Up Market Research published a new report titled “Rabies Diagnostics Market research report which is segmented by Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), by Technology (PCR, ELISA), By Players/Companies Bio-Rad Laboratories, Inc; and MyBioSourcecom, Inc; Aviva Systems Biology Corporation; Merck KGaA; Demeditec Diagnostics GmbH; Creative Diagnostics; Norgen Biotek Corp; Abbexa Ltd; Express Biotech International Inc; BioNote”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Rabies Diagnostics Market Report Segments:

The market is segmented by Diagnostic Methods (Fluorescent Antibody Test, Histologic, Serology), by Technology (PCR, ELISA).

Rabies Diagnostics Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Rabies Diagnostics Market

Overview of the regional outlook of the Rabies Diagnostics Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Rabies Diagnostics Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Rabies Diagnostics Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Fluorescent Antibody Test

                2. Histologic

                3. Serology

                1. PCR

                2. ELISA

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Rabies Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Rabies Diagnostics Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.